The Valley Desk

NCT01502956 · Interventional trial

Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)

Overall registry status Completed

Phase 3

Conditions Urinary Incontinence, Urge

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov